Clinical Trials for Innoviva Specialty Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Innoviva Specialty Therapeutics

Clinical Trials (4)

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

PHASE1Recruiting

48 participants

Started: Oct 30, 2025 · Completed: May 20, 2028

1 condition2 sponsors4 locations

Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension

PHASE4Enrolling by invitation

30 participants

Started: Sep 9, 2025 · Completed: Jun 30, 2030

1 condition2 sponsors2 locations

A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

PHASE2Recruiting

35 participants

Started: May 22, 2025 · Completed: Mar 19, 2029

1 condition2 sponsors4 locations

A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection

100 participants

Started: Apr 28, 2025 · Completed: Jan 31, 2029

1 condition1 sponsor4 locations